Wellington Management Group LLP Xenon Pharmaceuticals Inc. Transaction History
Wellington Management Group LLP
- $545 Billion
- Q3 2025
A detailed history of Wellington Management Group LLP transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 3,609,857 shares of XENE stock, worth $147 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
3,609,857
Previous 2,174,761
65.99%
Holding current value
$147 Million
Previous $68.1 Million
112.92%
% of portfolio
0.03%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding XENE
# of Institutions
240Shares Held
74.5MCall Options Held
169KPut Options Held
279K-
Avoro Capital Advisors LLC New York, NY5.4MShares$220 Million2.96% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.17MShares$170 Million1.42% of portfolio
-
Janus Henderson Group PLC London, X03.94MShares$161 Million0.08% of portfolio
-
Braidwell LP Stamford, CT3.61MShares$147 Million8.35% of portfolio
-
Capital International Investors Los Angeles, CA3.18MShares$130 Million0.02% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.54B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...